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Abstract
 
Promiscuous expression of tissue-specific self-antigens in the thymus imposes T cell tolerance
and protects from autoimmune diseases, as shown in animal studies. Analysis of promiscuous
gene expression in purified stromal cells of the human thymus at the single and global gene level
documents the species conservation of this phenomenon. Medullary thymic epithelial cells over-
express a highly diverse set of genes (
 
 
 
400) including many tissue-specific antigens, disease-
associated autoantigens, and cancer-germline genes. Although there are no apparent structural
or functional commonalities among these genes and their products, they cluster along chromo-
somes. These findings have implications for human autoimmune diseases, immuno-therapy of
tumors, and the understanding of the nature of this unorthodox regulation of gene expression.
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Introduction
 
Self/nonself discrimination is an essential property of adaptive
immunity. The T cell repertoire acquires a state of self-
tolerance specific for each individual by imprinting different
fates on developing immature T cells depending on their
propensity to recognize self. The extent of self-tolerance is
necessarily dictated by the diversity of self-antigens accessible
to the nascent repertoire within the thymus, when lym-
phocytes are most sensitive to tolerance induction. Although
this diversity of self-antigen display may be high due to distinct
APC subsets in the thymus, each presenting its unique sets
of self peptides (1), it has been held inconceivable that the
immunological “self” can be comprehensively represented
in the thymus. This reasoning is particularly true for “tissue-
specific” self-antigens, which play a prominent role in most
common autoimmune diseases and by definition should be
restricted in their expression to lineage-specific cells of the
respective organ. Various mechanisms collectively known
as peripheral tolerance have been described which offer an
explanation for this conundrum (2).
More recently, however, the relative contributions of
central versus peripheral tolerance have been reevaluated
based on accruing evidence that tissue-specific antigens are
expressed within the thymus and displayed there for reper-
toire selection. This physiological expression of tissue-specific
antigens by thymic epithelial cells (TECs), in particular
medullary TECs (mTECs), has been termed promiscuous
as distinguished from ectopic (3, 4). Promiscuous gene expres-
sion is a cell-autonomous property of mTECs and is main-
tained during the entire period of thymic T cell output (3).
By inclusion of numerous self-antigens expressed by different
parenchymal organs, this mechanism widens the scope of
central tolerance in a manner not anticipated by original
concepts of self-tolerance (5).
Although promiscuous gene expression by mTECs and
its role in self-tolerance in mice are by now undisputed, it is
still unclear whether this tolerance mechanism has been
conserved across species barriers during evolution including
humans. This issue is of particular interest in view of the
recent report showing that the rare human Autoimmune
Polyglandular Syndrome (APS) (6), a recessive autosomally
inherited monogenic disease, is modeled by mice deficient
in the autoimmune regulator (
 
Aire
 
) gene (7, 8). These mutant
mice display a partial defect in promiscuous gene expression
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(8). This important finding offers a valuable opportunity to
link a host of experimental data on tolerance mechanisms
and their failure to the human situation, provided that pro-
miscuous gene expression, its biological role, and molecular
regulation are strictly conserved among mouse and humans
(9). Several studies reported on the expression of selected
autoantigens in human thymus, prominent examples being
insulin, proteolipid protein (PLP), and myelin basic protein
(MBP); yet, the identity of the cells expressing these tissue
antigens remained ill defined and controversial (10–15). The
identification and isolation of the responsible cell type in
mice, however, has been a prerequisite to unambiguously
confirm expression of certain tissue antigens of low abun-
dance. Although almost all known or suspected autoanti-
gens of common autoimmune diseases could be detected in
murine mTECs by RT-PCR as far as analyzed, the full ex-
tent of expression of tissue-specific genes in the thymus re-
mains to be defined. The array of promiscuously expressed
genes being controlled by the transcriptional (co) factor Aire
in mice implied that this gene pool extends beyond the col-
lection of autoantigens known to be targeted in tissue-spe-
cific autoimmunity (8). A comprehensive expression analy-
sis of promiscuously expressed genes may not only identify
new candidate autoantigens but also reveal structural or
functional commonalities among these genes and thus offer
clues as to their molecular regulation.
Based on the isolation of pure thymic stromal cells of hu-
man thymus and an improved protocol for amplification of
small RNA amounts (16, 17), we show that promiscuous
gene expression is highly conserved between mouse and
human. The array of promiscuously expressed genes in hu-
man mTECs is diverse with regard to gene ontology, tissue
specificity, and chromosomal allocation. They encompass
clinically relevant autoantigens and tumor antigens includ-
ing cancer-germline antigens. The clustered location within
the genome points to epigenetic mechanisms to control at
least in part the expression of this gene pool.
 
Materials and Methods
 
Tissues.
 
Samples of thymic tissue from five patients (014: male,
8 mo; 015: male, 18 mo; 017: male, 5 mo; 018: female, 5 mo; and
019: female, 2 mo) were obtained in the course of corrective car-
diac surgery at the Department of Cardiac Surgery, Medical
School, University of Heidelberg. This study has been approved by
the Ethics Committee of the University of Heidelberg.
 
Isolation of Human Thymic Cells.
 
Pieces of thymic tissue were
minced into very small fragments and stirred in RPMI-1640 me-
dium on ice (2 
 
 
 
 10 min) to remove the majority of thymocytes.
After stepwise digestion with collagenase-dispase (3 
 
 
 
 20 min,
37
 
 
 
C) and trypsin-EDTA (3 
 
 
 
 15 min, 37
 
 
 
C), DCs were purified
according to a protocol described previously (18). Briefly, rosettes
from the pooled collagenase-dispase fractions were dissociated for
5 min by incubation with EDTA/PBS (25 mM, 37
 
 
 
C). After en-
richment by a one-step Percoll gradient (
 
 
 
 1.07 g/cm
 
3
 
, 1.700 
 
g
 
,
10 min, 4
 
 
 
C), low density cells were incubated with mAbs anti-
CD3 (OKT3; American Type Culture Collection) and anti-
CD19 (HD37; DKFZ-Heidelberg), and remaining thymocytes
and contaminating B cells were depleted with anti–pan-IgG
Dynabeads (Dynal). Cells were stained with FITC-conjugated
mAb HLA-DR (BD Biosciences), PE-conjugated mAb anti-
CD11c (BD Biosciences), and epithelial cell adhesion molecule
(EpCAM; clone HEA125)-biotin/sav-CyChrome. Cells were
sorted with a FACSVantage Plus cell sorter, and EpCAM
 
pos
 
 epi-
thelial cells were excluded by appropriate gating. TECs were iso-
lated from the third trypsin fraction. Cells were enriched in Per-
coll (
 
 
 
 1.07 g/cm
 
3
 
, 1,700 
 
g
 
, 10 min, 4
 
 
 
C), and myelogenic cells
were depleted from the low density fraction with anti–CD45
Dynabeads (cells:beads 
 
 
 
 1:3). After staining with mAbs biotiny-
lated EpCAM/sav-PE and cortical dendritic reticulum antigen 2
(CDR2)-Alexa488 (Alexa Fluor 488 Protein Labeling kit; Molec-
ular Probes) (19), cells were sorted, excluding remaining myelo-
genic (CD45
 
 
 
) cells (stained with mAb anti–CD45-Cychrome;
Immunotech). Thymocytes were sorted as CD3
 
high
 
 cells (mAb
anti–CD3-FITC; BD Biosciences) from the medium fraction.
Dead cells were always excluded with propidium iodide (1 
 
 
 
g/
ml). The average cell yield per thymus aliquot (3–5 cm
 
3
 
, equiva-
lent to 15 mouse thymi) was 6 
 
 
 
 10
 
5
 
 mTECs, 10
 
6
 
 cTECs, and
6 
 
 
 
 10
 
5
 
 DCs.
 
Immunohistochemistry.
 
Human thymic tissue pieces were em-
bedded in Tissue-Tek (Sakura) and snap frozen in liquid nitro-
gen. Cryosections (4 
 
 
 
m) were fixed in ice-cold acetone for 20
min, air dried, and soaked in PBS supplemented with 0.01%
Tween 20. To reduce endogenous peroxidase activity, sections
were incubated with H
 
2
 
O
 
2
 
 in 0.1 M sodium acetate (0.3%) for 20
min, and unspecific binding sites were blocked by incubation
with 5% mouse serum in PBS/Tween for 20 min. Specific stain-
ing was performed at room temperature in PBS/Tween for 45
min with the biotinylated mAbs CDR2 (cortex) and HEA125
(medulla), respectively. After a 45-min incubation with peroxi-
dase-conjugated streptavidin (Jackson ImmunoResearch Labora-
tories), sections were developed with a substrate buffer containing
5 mM 3-amino-9-ethylcarbazol and 0.15% H
 
2
 
O
 
2
 
 in 0.1 M so-
dium acetate.
 
RNA Preparation and cDNA Synthesis.
 
RNA was isolated
from single-cell suspensions with the High Pure RNA Isolation
kit (Roche) and eluted in 50 
 
 
 
l H
 
2
 
O. 48 
 
 
 
l of this RNA solution
or 1 
 
 
 
g total RNA from commercially available control tissues
(Stratagene) were treated with 6 U DNase I (Invitrogen) and re-
verse transcribed into cDNA with Oligo(dT)
 
20
 
 Primer and Super-
script II Reverse Transcriptase (Invitrogen); this was followed by
RNase H digestion (Promega).
 
RT-PCR Analysis.
 
PCRs were performed in a final volume of
25 
 
 
 
l with 1 U REDTaq DNA Polymerase (Sigma-Aldrich). Final
concentrations of the PCR mix were: 250 nM for each primer,
200 
 
 
 
M dNTP (MBI Fermentas), 10 mM Tris-HCl (pH 8.3), 50
mM KCl, 1.1 mM MgCl
 
2
 
, and 0.01% gelatin. The amplification
was performed in a Thermalcycler (PTC-100; MJ Research) under
standard conditions: a single denaturation step at 94 
 
 
 
C for 3 min
followed by either 35 (GAD65, IA-2, TPO, H/K-ATPase 
 
  
 
and
 
  
 
chain
 
 
 
Golli-MBP, myelin-oligodendrocyte–associated glycoprotein
 
(
 
MOG), RetSAg, IRBP, MAGE-A1, -A3, -A4, NY-ESO-1,
MART-1, tyrosinase), 33 (PLP), 32 (insulin, GAD67, thyroglobu-
lin, DC-LAMP), 30 (WHN, AIRE, collagen II), or 21 cycles (for
GAPDH normalization) of 94 
 
 
 
C for 1 min, 54–62
 
 
 
C for 1 min
and 72
 
 
 
C for 2 min, followed by a final extension step of 72
 
 
 
C
for 10 min. The following oligonucleotide pairs were used
(sense and antisense, respectively): AIRE, 5
 
 
 
-TGCCAAGGATGA-
CACTGC-3
 
 
 
 and 5
 
 
 
-TTCCAGAGTAGAGAAGTGGGGC-3
 
 
 
;
collagen II, 5
 
 
 
-CTGGCTCCCAACACTGCCAACGTC-3
 
 
 
 and
5
 
 
 
-TCCTTTGGGTTTGCAACGGATTGT-3
 
 
 
; DC-LAMP, 5
 
 
 
-
GCACGATGGCAGTCAAATGA-3
 
 
 
 and 5
 
 
 
-GAAGTATCTC- 
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CGAGGTGAAA-3
 
 
 
; GAD65, 5
 
 
 
-TGCTCCAAAGTGGATGT-
CAACTA-3
 
 
 
 and 5
 
 
 
-ATGTTAGTATTTGCTGTTGATGTCA-
3
 
 
 
; GAD67, 5
 
 
 
-ATGGCGTCTTCGACCCCATCTT-3
 
 
 
 and
5
 
 
 
-AGCTGGTTGAAAAATCGAGGA-3
 
 
 
; GAPDH, 5
 
 
 
-AAC-
AGCCTCAAGATCATCAGC-3
 
 
 
 and 5
 
 
 
-CTGTTGCTG-
TAGCCAAATTCG-3
 
 
 
; Golli-MBP, 5
 
 
 
-AAACCACGCAG-
GCAAACG-3
 
 
 
 and 5
 
 
 
-AGGGTCTCTTCTGTGACG-3
 
 
 
; H/K-
ATPase 
 
 
 
 chain, 5
 
 
 
-GTCAACGAGCCCCTGGCTGC-3
 
 
 
 and
5
 
 
 
-GTAGAGTTCCTGGTCCCACC-3
 
 
 
; H/K-ATPase 
 
 
 
 chain,
5
 
 
 
-GCAGGAGAAGAAGACGTGT-3
 
 
 
 and 5
 
 
 
-GGATGTTGA-
GGAGCTTC-3
 
 
 
; IA-2, 5
 
 
 
-AGACAGGGCTCCAAATCTTGC-
3
 
 
 
 and 5
 
 
 
-GGCATGGTCATAGGGCAGGAA-3
 
 
 
; insulin, 5
 
 
 
-
CAACACCTGTGCGGCTCA-3
 
 
 
 and 5
 
 
 
-TATTCCATCTCT-
CTCGGTGCAG-3
 
 
 
; IRBP, 5
 
 
 
-GCTGATAACTATGCCTCT-
GCCG-3
 
 
 
 and 5
 
 
 
-CTTCTTCCAGATGTGCTCCACC-3
 
 
 
;
MAGE-A1, 5
 
 
 
-CGGCCGAAGGAACCTGACCCAG-3
 
 
 
 and
5
 
 
 
-GCTGGAACCCTCACTGGGTTGCC-3
 
 
 
; MAGE-A3, 5
 
 
 
-
TGGAGGACCAGAGGCCCCC-3
 
 
 
 and 5
 
 
 
-GGACGATTATC-
AGGAGGCCTGC-3
 
 ; MAGE-A4, 5 -GAGCAGACAGGCCA-
ACCG-3  and 5 -AAGGACTCTGCGTCAGGC-3 ; MART-1,
5 -ACTGCTCATCGGCTGTTG-3  and 5 -TTCAGCATGT-
CTCAGGTG-3 ; MOG, 5 -CTCCTCCTCCAAGTGTCTTC-
3  and 5 -GTAGCTCTTCAAGGAATTGC-3 ; NY-ESO-1, 5 -
AGTTCTACCTCGCCATGCCT-3  and 5 -TCCTCCTCCA-
GCGACAAACAA-3 ; PLP/DM20, 5 -ACTACAAGACCAC-
CATCTGC-3  and 5 -CCATACATTCTGGCATCAGC-3 ;
RetSAg, 5 -GCCAATGTGGTTCTCTACTCG-3  and 5 -
CGAGCAAACTCCTCAAAAACTA-3 ; thyroglobulin, 5 -
CCCTGGCCTGACTTTGTACC-3 ; and 5 -TCACTTGCTG-
TAGGTCTTAGAGCC-3 ; TPO, 5 -TACAAGCATCCTGA-
CAACATCG-3  and 5 -ATTCTCCACGCTCTCTGG-3 ; tyro-
sinase, 5 -TTGGCAGATTGTCTGTAGCC-3  and 5 -AGG-
CATTGTGCATGCTGCTT-3 ; and WHN (FOXN1), 5 -
TTCCTTACTTCAAGACAGCAC-3  and 5 -GGTTCTTGC-
CAGGAATGG-3 . All primers were synthesized in the oligonu-
cleotide synthesis facility of the German Cancer Research Center
and were, wherever possible, designed to span at least one intron.
Reaction products were separated on a 1.2% agarose gel in TAE
(40 mM Tris-acetate, 1 mM EDTA) containing ethidium bromide
and revealed with the Lumi-Imager F1 Workstation (Roche). Lu-
miAnalyst 3.0 software (Roche) was used to quantify PCR prod-
ucts for normalization to GAPDH expression before testing pro-
miscuous gene expression.
Microarray Analysis. Total RNA from thymic samples 017
and 018 (4.5  l, corresponding to  6   104 mTECs, 104 cor-
tical TECs (cTECs), and 6   104 DCs) was preamplified and
biotinylated in two independent experiments by two rounds
of cDNA synthesis and in vitro transcription as described pre-
viously (16, 17, 20). Biotinylated aRNA was hybridized to
Gene Chip Arrays (Human Genome U95Av2; Affymetrix)
and sequentially stained in a GeneChip Fluidics Station 400
(Affymetrix) with streptavidin-PE (Molecular Probes), bio-
tinylated antistreptavidin mAb (Linaris), and again with strep-
tavidin-PE. Arrays were scanned with a Gene Array Scanner
(Hewlett Packard) and evaluated using the software Micro-
array Suite 5.0 (Affymetrix) and Excel 97 (Microsoft). To
identify genes overexpressed in the different thymic cells, com-
parison analyses between arrays from each dataset were per-
formed. We defined overexpression of a probe set as reliable
when the following criteria were met in both experiments:
present or marginally present, increased or marginally in-
creased, and signal log ratio low  1 compared with the refer-
ence subset.
Statistical Analysis. To test for statistical significance of clus-
tering, we used randomized lists of genes from the same chip for
comparison according to the method described by Roy et al. (21)
Briefly, we produced random lists of genes of the same length as
the number of genes overexpressed in mTECs. We calculated the
number of pairs of genes for each of the lists that were located on
the same chromosome within a distance of 35, 50, 80, 120, 200,
300, 500, 1,000, 2,000, 3,000, or 5,000 kb. The numbers ob-
tained from the list of genes overexpressed in mTECs were com-
pared with those obtained from 10,000 random lists. P-values
were calculated from the empirical distribution (22). To test the
number of clusters of a given size, we calculated the number of
genes that were located within a sliding window of 10 consecu-
tive genes, taking the highest local maximum as cluster size. The
frequency of clusters of a given size was determined for both the
list of overexpressed genes and for 1,000 random lists.
Online Supplemental Material. Fig. S1 shows RT-PCR results
for the expression of selected genes in thymic stromal cells. Table
S1 lists all genes overexpressed in mTECs versus cTECs, Table S2
lists all genes overexpressed in cTECs versus mTECs, and Table
S3 lists genes overexpressed in mTECs and which presumably are
involved in gene regulation. Supplemental material is available at
http://www.jem.org/cgi/content/full/jem.20031677/DC1.
Results
Purification of Stromal Cells of the Human Thymus. A proto-
col previously established for the isolation of thymic stro-
mal cells in mice has been adapted to purify the corre-
sponding cell types from the human thymus (3). A
combination of stepwise enzymatic digestion, density cen-
trifugation, magnetic cell depletion, and multicolor sorting
yielded pure populations of mature thymic DCs, cTECs,
and mTECs. The differential coexpression of EpCAM and
CDR2, a cTEC-specific antigen (19), allowed separation
of the latter two cell subsets (Fig. 1 a). Although CDR2 is
specifically expressed on cTECs and rare nonepithelial cells
of the medulla, EpCAM is expressed both on mTECs and
at 10-fold lower levels on cTECs. This expression pattern
thus yields cTECs, i.e., CD45 , CDR2hi, EpCAMint, and
mTECs, i.e., CD45 , CDR2 , EpCAMhi. Thymic DCs
were isolated as HLA-DRhi, CD11c , EpCAM  cells ac-
cording to a previously published protocol (18). The cell
yield per tissue volume was comparable between mouse
and human. The purity of these populations was verified by
PCR expression analysis of indicator genes, i.e., FOXN1
was expressed in mTECs and cTECs but not in DCs,
AIRE in mTECs, and weakly in DCs and DC-LAMP in
DCs and surprisingly also in mTECs (Fig. 1 b). We pre-
sume that expression of DC-LAMP in mTECs either re-
flects promiscuous expression or a physiological feature of
mTECs rather than DC contamination. Based on these ex-
pression patterns, we regarded these populations as suffi-
ciently pure to pursue gene expression analysis.
Promiscuous Gene Expression in Medullary Epithelial Cells Is
Conserved between Mice and Man. We first assessed the ex-
pression of organ-specific autoantigens of putative clinical
relevance in these cell types isolated independently from
five human thymi. Examples of self-antigens of the endo-
crine pancreas, thyroid, stomach, brain, cartilage, and eyePromiscuous Gene Expression in Human Thymic Epithelium 158
were analyzed by RT-PCR (Table I). All antigens were re-
producibly expressed in mTECs with the exception of
GAD65 and the H/K-ATPase   chain, which were below
detection in all thymic cells analyzed. Messenger RNAs for
PLP and Golli-MBP showed a broader expression pattern
beyond mTECs, a finding already reported for the mouse
thymus (3, 4). The unequivocal detection of MOG
mRNA, the intrathymic expression of which had been
controversial (14), documents the gain in sensitivity when
purified cells compared with whole thymus or laser-cap-
tured medullary areas were analyzed.
Expression of a second class of peripheral autoantigens,
so called tumor-associated antigens, has been claimed to be
absent from the thymus and the peripheral immune system
and consequently thought to be exempted from self-toler-
ance (23, 24). We tested the expression pattern of four
members of the cancer-germ line group (MAGE–A1, -A3,
-A4, and NY-ESO-1) and two members of the group of
melanoma differentiation antigens (MART-1 and tyrosi-
nase), some of which had been selected for current clinical
trials (25). Cancer-germ line antigens are expressed in male
germ cells in uterus and various tumors and melanoma dif-
ferentiation antigens in melanocytes and melanomas (26).
All of these genes were detectable in purified mTECs, al-
beit with interindividual differences in their expression lev-
els (Fig. 2). Whereas MAGE-A1 was only detectable in one
out of five thymi, MART-1 was present in all five samples.
It is also notable that the expression levels were much
lower than in the corresponding peripheral tissues. Not-
withstanding these qualifications, the data show that tu-
mor-associated antigens previously thought to be secluded
from the immune system are also expressed by mTECs and
Figure 1. Isolation of distinct stromal cells of the
human thymus. (a) Sort regions selected for the iso-
lation of thymic stromal cell subsets; the coexpression
profile for CDR2 and EpCAM of low density,
CD45 negative trypsin-digested cells is shown.
Cortical TECs are defined as CDR2hi, EpCAMint,
and mTECs as CDR2 , EpCAMhi. The corre-
sponding histological staining patterns of both Abs
are shown. Thymic DCs are defined as CD11cint/hi,
HLA-DRhi, EpCAMneg cells of low density. (b) Ex-
pression of a selected panel of marker genes was
assessed in purified cTECs, mTECs, and DCs of
five thymi by RT-PCR. The cell type–specific
expression patterns document the purity of the respec-
tive  subsets. The expression of DC-LAMP in
mTECs probably reflects its promiscuous expression
rather than contamination by DCs. The amount of
input cDNA was normalized according to signals
obtained for GAPDH in a titration experiment (not
depicted).Gotter et al. 159
thus presumably displayed to developing T cells. The selec-
tivity of this expression in mTECs underpins the unique
role this cell type plays in promiscuous gene expression.
The high score with which “arbitrarily” selected genes
were found to be expressed in mTECs and the diversity of
these promiscuously expressed genes in mice and man im-
plies that this gene pool is complex and comprehensive. To
more precisely delineate this gene pool, we defined the
transcriptome of these cell types by microarray analysis.
Promiscuously Expressed Genes Are Highly Diverse. We
performed a comparison of the gene expression profiles of
cTECs, mTECs, DCs, and mature thymocytes. RNA was
isolated from independent replicates of each subset, and
amplified cDNA were prepared by two rounds of cDNA
synthesis and in vitro transcription steps and hybridized to
GeneChip® oligonucleotide arrays (Affymetrix U95Av2)
containing  12,500 probe sets. Scanned arrays were ana-
lyzed with Affymetrix software Microarray Suite 5.0 to
identify cell type-specific gene expression profiles and assess
quantitative difference in gene expression among these
subsets. Calculation of the fold change in gene expression
was based on the Lower Confidence Bound as a measure of
enrichment of gene expression. Genes for which the signal
log ratio low was  1 (equal to a difference of at least two-
fold) and which at the same time were designated increased
or marginally increased were considered (see Materials and
Methods). Comparisons were performed among the differ-
ent cell subsets within each experiment, and only genes ful-
filling these criteria in both comparisons were considered
(Fig. 3, a–c).
The mutual comparisons of mTECs with cTECs, DCs,
and thymocytes revealed in each case a much higher num-
ber of genes being expressed in mTECs compared with the
reference population (Fig. 3, a compared with c). The
number of differentially expressed genes correlates with the
ontogenetic kinship of these cell lineages (Fig. 3 d). We re-
gard the comparison between mTECs and cTECs as most
Table I. Cell Type–specific Expression Pattern of Selected Self-
antigens Purportedly Associated with Common Autoimmune Diseases
Organ Autoantigen
Antigen-presenting cell
cTECs mTECs DCs
Pancreas Insulina                  
GAD67a                  
GAD65a                  
IA-2a                  
Thyroid Thyroglobulin                  
TPOa                  
Stomach H/K-ATPase                    
H/K-ATPase                    
Brain Golli-MBP                  
PLP/DM20                  
MOG                  
Eye RetSAga                  
IRBPa                  
Cartilage Collagen II             –   – – –
Expression was analyzed by RT-PCR applying 30–35 cycles.
Quantitative differences in signal strength were not considered (see also
Fig. S1).  , present;  , absent;  , not determined.
aThe TEC-specific expression pattern of antigens has been confirmed
in six additional thymi. In addition, mRNA expression of albumin,
 -fetoprotein, C-reactive protein, and erythropoietin in mTECs has
been found in six thymi (not depicted).
Figure 2. Thymic expression of tumor-associated antigens.
Expression of selected tumor-associated antigens in thymic
stromal cells of five thymi was assessed by RT-PCR. Ex-
pression in each case was confined to mTECs. Note inter-
individual variations and the difference in signal strength
compared with control tissues. The amount of input
cDNA was normalized according to signals obtained for
GAPDH in a titration experiment (not depicted).Promiscuous Gene Expression in Human Thymic Epithelium 160
informative, given the close relationship between these two
cell types. It is worth noting that 70% of the signals in this
case differed by more than fourfold (SLR   2). The pool
of genes overexpressed in mTECs comprised 443 genes
(Table S1, available at http://www.jem.org/cgi/content/
full/jem.20031677/DC1), and the pool overexpressed in
cTECs comprised 162 genes (Table S2, available at http://
www.jem.org/cgi/content/full/jem.20031677/DC1).
The ratio between mTECs and cTECs pool as a measure of
differential gene expression between these two cell types
was remarkably invariant between man and mouse (2.7
versus 2.6; Derbinski, J., personal communication). How-
ever, this ratio is probably higher for two reasons. First, the
pool of genes overexpressed in mTECs is underestimated,
since many genes detected by RT-PCR did not fulfill the
criteria of our array comparison. This was not unprece-
dented since the array analysis is known to be less sensitive
than RT-PCR analysis. Note that mTEC-specific genes
(i.e., absent in cTECs) were predominantly expressed at
low levels, in concordance with the low signal strength of
promiscuously expressed genes in mice (8) (Fig. 3 a). Sec-
ond, the cTEC-specific pool is overestimated, since it
comprises many genes specific for T cells due to contami-
nation of this subset by thymic nurse cells.
The genes overexpressed in mTECs fall into at least two
categories: those which constitute the differentiation pro-
gram of this epithelial cell lineage and those which are re-
garded as tissue specific, i.e., expressed in a promiscuous
manner. We based the gene assignment on data reported by
Su et al. (27). In this study, gene expression in  40 human
tissues and cell lines had been assessed by gene array analysis
using the Affymetrix U95A arrays. This assignment, how-
ever, remains preliminary, since different reports on tissue
specificity of gene transcription vary widely, depending on
the methods applied. Notwithstanding this qualification, the
expression of at least 80 out of 443 genes in this pool can be
qualified as tissue restricted based on their reported expres-
sion pattern and/or functional designation (27). Most tissues
including mammary gland, liver, muscle, kidney, pancreas,
placenta, thyroid, salivary glands, testis, and prostate are rep-
resented as shown for 80 selected genes (Table II).
Given the recent demonstration that Aire, a putative
regulator of gene transcription, partly controls promiscu-
ous gene expression in murine mTECs (8), we searched for
gene products which are known or suspected to control
gene expression at the genetic or epigenetic level. 25 genes
overexpressed in mTECs submit to these criteria, yet none
of these factors appeared to be specific for mTECs. Note-
worthy, AIRE showed the highest enrichment in mTECs
(Table S3, available at http://www.jem.org/cgi/content/
full/jem.20031677/DC1).
Although global gene analysis in mTECs documents the
diversity of promiscuously expressed genes, it does not re-
veal commonalities with regard to structure, function, or
gene ontology, which may have selected this set of genes.
Alternatively, promiscuous gene expression may target cer-
tain chromosomal domains via epigenetic control mecha-
nism. Hence, we analyzed the chromosomal and subchro-
mosomal location of this gene pool.
Promiscuously Expressed Genes Cluster along the Chromo-
some. The chromosomal position of 415 of the 443 genes
overexpressed in mTECs had been mapped. The relative
distribution of these genes on the various chromosomes
showed no marked under- or overrepresentation for partic-
ular chromosomes compared with the distribution of all
mapped genes of the array (Fig. 4 a). Since the two datasets
Figure 3. Comparative global gene expres-
sion in thymic stromal cells. The relative
expression levels as detected by gene arrays
are depicted as scatter plots of two experi-
ments (blue and red). (a) Signal strength of
genes present or marginally present in
mTECs in both comparisons and present,
marginally present, or absent in cTECs. (b)
Signal strength of genes present or marginally
present in cTECs in both comparisons and
present, marginally present, or absent in
mTECs. (c) Signal strength of genes present
or marginally present in mTECs in both
comparisons and present, marginally
present, or absent in DCs. Note the higher
proportion of genes specific for mTECs
(absent in cTECs) and their low expression
levels. (d) Quantitative analysis of relative
gene expression in mutual comparisons
between cTECs, mTECs, DCs, and mature
thymocytes. Numbers above bars denote
the frequency of genes overexpressed in
each case. The gene pool overexpressed in
mTECs versus cTECs (red bar) has been
analyzed in more detail. For details of cal-
culations, see Materials and Methods. TC,
thymocytes.Gotter et al. 161
are from a male and a female thymus, we did not evaluate
the Y chromosome. Notably, we did not find preferential
X chromosomal locations as reported for genes expressed
in spermatogonia, which partially overlap with genes ex-
pressed in mTECs (28, 29). Next, we analyzed whether
promiscuously expressed genes are clustered along chromo-
somes. Recently, several studies in different species showed
that genes coexpressed in a particular tissue are aligned in
clusters (21, 30). We specifically calculated the probability
with which 2 genes of the 415 gene pool would occur
within a DNA window of 200 kb. This number was com-
pared with the corresponding probabilities of 400 ran-
domly sampled genes present on the arrays probing 10,000
permutations. There was a highly significant clustering of
overexpressed genes (Fig. 4 b). This difference also holds
when windows ranging between 35 and 5,000 kb were
tested (not depicted). In addition, the experimental and
random frequencies of 2, 3, 4, and 5 genes being clustered
within a window of 10 adjacent genes present on the arrays
irrespective of genetic distance has been calculated. This
analysis revealed a clear overrepresentation of triplets and
quadruplets in the experimental gene set compared with
1,000 random draws of the same number of genes (Fig. 4
c). An example of 10 genes clustered within 5 Mbp en-
compassing genes of different ontology, i.e., three members
of the S100 gene family, MUC1 and SELENBP1, predom-
inantly expressed in the liver (27) is shown in Fig. 4 d. We
emphasize that we did not exclude homologous genes in
this analysis, which may have arisen from gene duplication,
since the expression pattern of individual members of such
gene families may also reflect promiscuous gene expression.
Thus, different type II keratin genes, including hair keratins
were coexpressed in purified mTECs despite their differen-
tial regulation in epithelial cells of other tissues (31, 32).
Discussion
This study documents that promiscuous gene expression
by thymic epithelial cells is highly conserved between
mouse and human. This correspondence at the expression
level is most likely based on a common molecular regula-
tion in both species. The conservation lends credit to anal-
Figure 4. Genomic distribution of mTECs overexpressed genes. (a) Chromosomal assignment of genes overexpressed in mTECs versus cTECs.
Pooled data from a female and a male donor have been analyzed. The relative distribution of all transcripts present on the chip with known chromosomal
assignment was normalized to 1 for each chromosome. The absolute number of genes overexpressed in mTECs per chromosome is indicated above the
bars. The relative distribution of mTECs genes shows no particular chromosomal preferences. n.d., not determined. (b) Distribution of the number of
neighbors in 10,000 random gene lists that are located on the same chromosome within a distance of 200 kb (calculated from transcription start). The
median and the 95th percentile of the distribution are marked by blue and green lines, respectively. The actually observed number in the list of 415 genes
overexpressed in mTECs is indicated by a red line. (c) Number of clusters of size 2, 3, 4, and 5 within a window of 10 consecutive genes. The gray bars
refer to the number in the list of genes overexpressed in mTECs and the white bars to the number in 1,000 random gene lists. The SD among these
1,000 lists is indicated by the error bar. (d) Clustered expression of 10 promiscuously expressed genes in mTECs within 5 Mbp on chromosome 1.
SELENBP1, selenium binding protein 1; S100 A, calcium binding protein A; FLG, filaggrin; IVL, involucrin; SPRR1B, small proline rich protein 1B;
NPR1, atrial natriuretic peptide receptor A; MUC1, mucin 1.Promiscuous Gene Expression in Human Thymic Epithelium 162
Table II. Expression of Tissue-specific Genes in Human TECs
Symbol Name/Function Symbol Name/Function
Mammary gland
CSN1 Casein SCGB2A2 Mammaglobin
CSN2 Casein
Adipose tissue
APM2 Unknown
Liver
AADAC Esterase FGG Fibrinogen
APOA1 Apolipoprotein PCK2 PEP-carboxykinase
APOC3 Apolipoprotein SERPINA5 Antitrypsin
DPYS Dihydropyrimidinase UGT2B10 UDP-glucuronosyl-transferase
FGB Fibrinogen
Muscle
ACTC Alpha actin MYH7 Myosin 
AK1 Adenylate kinase MYL1 Myosin
CASQ2 Calcium-binding protein MYL2 Myosin
CHRNA1 Acetylcholine receptor TNNC1 Troponin
CSRP3 Heart-LIM protein TNNI1 Troponin
ENO3 Enolase TNNT2 Troponin
MB Myoglobin TTN Myofilament
Nervous system
ADAM23 Metalloproteinase HAPIP Vesicle transport
CADPS Calcium-binding protein KCNK1 Potassium channel
CALB1 Calbindin NEF3 Neurofilament
CCK Prohormone PADI2 Deiminase
CHGB Secretogranin PCDH8 Protocadherin
CNR1 Receptor PRSS12 Neurotrypsin
FGF1 Growth factor SST Somatostatin
GABBR1 Receptor SV2B Synaptic vesicle protein
GABRA5 GABA receptor SYNGR1 Synaptogyrin
GAL Galanin SYT1 Synaptotagmin
GPR37 G protein–linked receptor TAC1 Neuropeptide
Kidney
ABP1 Membrane glycoprotein TM7SF1 Transmembrane protein
SPP1 Osteopontin UGT1A4 UDP-glucuronosyl-transferase
Pancreas
AMY2B Amylase PRSS2 Trypsin II
ELA3A Elastase PRSS4 Trypsin III
GAD1 Glutamate-decarboxylase RNASE1 RNase A1
GCG Glucagon SCGN Secretagogin
LEFTB L/R determination factor B
Placenta
CGA Glycoprotein hormone PRG2 Proteoglycan
CLDN4 Tight junction protein SDC1 Membrane protein
CSH2 Placental lactogen hormone SEMA3B Semaphorin
Prostate
ACPP Phosphatase
(continues)Gotter et al. 163
ogies frequently drawn between experimental disease mod-
els and human autoimmune diseases. In the context of this
study, this applies in particular to central tolerance as im-
parted by promiscuous gene expression and to Aire / 
mice and APS1 patients.
The isolation of purified thymic stromal cells of the hu-
man thymus has been a prerequisite to unambiguously and
reproducibly detect expression of certain genes in the hu-
man thymus. Thus, MOG expression, in contrast to other
myelin-specific antigens, had not been detected when
whole thymus tissue or laser-captured medullary regions
were analyzed (11, 14). Likewise, tumor-associated anti-
gens including differentiation antigens (e.g., tyrosinase and
MART-1) and cancer-germline antigens (i.e., the members
of MAGE-A group or NY-ESO-1) had been considered
absent from the thymus and the peripheral immune system
for this matter (23, 24). In both cases, it had been inferred
that spatial seclusion from the immune system precludes
self-tolerance to these antigens. The expression of these an-
tigens in mTECs, albeit at varying levels, is compatible
with self-tolerance induction to these antigens. Given the
gain in sensitivity by purifying mTECs, we conclude that
promiscuous gene expression in the human thymus can
only be reliably assessed in purified stromal cell subsets.
The expression analysis by RT-PCR documents a re-
markable degree of species conservation between mouse
and man. This does not only apply to the selection of genes
expressed (as far as analyzed by RT-PCR, all genes tran-
scribed in man are also expressed in mice except for Mage-a
[3, 4]) but also to the cell type–specific expression pattern.
All promiscuously expressed genes are found in mTECs, re-
emphasizing their unique role. This has been confirmed by
analysis of six additional thymi (unpublished data). How-
ever, expression was not always confined to mTECs; thus,
PLP and golli-MBP were also expressed at comparable lev-
els in cTECs, and this is true both for mouse and man (3, 4).
It is worth pointing out that GAD65 is apparently absent
from human mTECs and thus likely to be absent from the
human thymus. Absence of expression in the thymus and
predominant expression in a peripheral tissue, as is the case
for GAD65, is a particular liability for autoreactivity.
GAD65 has been suspected to be the inciting or at least one
of the initial autoantigens targeted in the early course of
Diabetes mellitus type 1 (DM T1) (33–37), and the reason
for this may be lack of central tolerance. In contrast,
GAD67 shows the inverse expression pattern. This could
explain the prevalence of specific autoantibodies to these
two antigens in the course of DM T1, which is inversely
correlated with their intrathymic expression levels (Fig. S1,
available at http://www.jem.org/cgi/content/full/jem.
20031677/DC1). A similar reasoning may apply to the two
chains of the proton ATPase pump of the stomach. Al-
though the   chain is clearly expressed in mTECs and DCs,
the   chain is at best marginally expressed in mTECs. In
the mouse model, the   chain but not the   chain is disease
inducing and protective when ectopically expressed in the
thymus (38). Thus, not only the absence of a particular
exon, as exemplified by PLP (39), but also lack of intrathy-
mic expression of an entire antigen may predispose to organ-
specific autoimmunity. This supposition is all the more likely,
since already moderate reductions in the levels of self-anti-
gen expression (two- to fourfold) seem to affect the degree of
self tolerance (40–43). A correlation between intrathymic
expression levels and autoantibody prevalence is less appar-
ent for insulin and IA-2. The wide range of insulin-specific
autoantibody prevalence in DM T1 may be due to varia-
tions in intrathymic expression levels of insulin. Such varia-
tions have been documented for this self-antigen (40–42).
The set of 443 genes overexpressed in mTECs compared
with cTECs delineates the extent and diversity of promiscu-
ous gene expression in a first approximation. The size of this
gene pool is comparable in mouse and man (555 versus 443
genes, respectively). It is certainly underestimated, since
most genes detected by PCR have not been found by global
gene analysis, despite representation on the chip. In addi-
tion, the U95Av2 array set represents only  1/3 of all hu-
man transcripts. Based on these considerations, we estimate
the pool to contain at least a total of 1,200–3,000 genes or
Table II. (continued)
Symbol Name/Function Symbol Name/Function
Respiratory tract
MUC4 Mucin TSPAN-1 Transmembrane protein
SCGB1A1 Uteroglobin
Thyroid
CLDN3 Tight junction protein
Salivary gland
PRB2 Secreted protein SLPI Protease inhibitor
Testis
GSTM3 Glutathione transferase SPAG6 Sperm antigen
Genes overexpressed in mTECs, as identified by array analysis, were evaluated for their function and/or tissue-specific expression based on the analysis
by Su et al. (27). Note the functional diversity of the selected genes and their broad tissue distribution.Promiscuous Gene Expression in Human Thymic Epithelium 164
5–10% of all transcripts, of which only part are likely to be
strictly restricted to a particular cell type. This estimate is
well in accord with the number of genes being regulated by
the Aire gene in mice, which, according to a recent report
ranges between 200 and 1,200 genes (8). Of note, Aire only
regulates a subset of promiscuously expressed genes.
The mTEC-overexpressed genes have no obvious struc-
tural or functional commonalities, they show no preference
for any chromosome (Fig. 4 a), and they represent most if
not all peripheral tissues (Table II). Despite this apparent ar-
bitrariness, the pool includes genes, which are of particular
physiological or pathophysiological relevance. Thus, human
mTECs express self-antigens known or suspected to be tar-
geted in common autoimmune diseases, like DM T1, Mul-
tiple Sclerosis, Hashimoto’s thyroiditis, Myasthenia gravis,
autoimmune gastritis, retinitis, and rheumatoid arthritis (Ta-
ble I). Most relevant to the role of AIRE in regulating pro-
miscuous gene expression, we find many candidate antigens
eliciting auto antibodies in APS-1 patients, e.g., thyroid
peroxidase, thyroglobulin, P450 cytochrome subfamilies,
and IA-2 expressed in mTECs (44, 45). Down-regulation
or erasure of expression of these genes due to AIRE muta-
tions may underlie the preference in organ pathology of
APS-1 patients. The high species conservation between
mouse and man strengthens a causal link between partially
defunct promiscuous gene expression in mTECs and result-
ant multiorgan autoimmunity as the underlying pathophysi-
ology of this rare human autoimmune syndrome.
The unequivocal and specific expression of tumor-associ-
ated antigens in human mTECs, in particular those of the
cancer-germ line group, calls for a reappraisal of their im-
mune-privileged status. Cancer-germ line antigens had so far
only been found in male germ cells, a few cells of the uterus
and tumor cells (25, 26). Since male germ cells lack MHC
expression and the testis is sequestered from circulating lym-
phocytes, it had been assumed that these antigens are pre-
cluded from tolerance. Given the exquisite sensitivity of cen-
tral tolerance, even the low and variable expression of these
tumor antigens may result in some degree of self-tolerance
(46, 47). Whether central tolerance contributes to the lim-
ited success of current clinical vaccination trials with peptides
derived from these antigens remains conjectural (48).
Promiscuous expression of certain genes implies that de-
velopmental patterns of gene expression are overridden.
Thus, self-antigens specifically induced or up-regulated
during pregnancy (i.e., casein) are already found in the
postnatal thymus. This “uncoupled” expression offers an
explanation for a long-standing enigma, the induction of
self-tolerance to antigens, which arise only in adulthood,
i.e., during puberty and pregnancy. Likewise sex-specific
gene expression is abolished. Testis-specific antigens, i.e.,
sperm-associated antigen 6, are expressed in female mTECs
and placental antigens, i.e., placental lactogen hormone, in
male mTECs. As a corollary, certain antigens are probably
only expressed in mTECs and no other cell of the body.
Although promiscuously expressed genes are quite di-
verse, they still incompletely represent the vast array of tis-
sue-specific self-antigens. How is self-tolerance then pre-
served to those antigens which are not expressed by
mTEC-like GAD65, notwithstanding peripheral tolerance?
As argued elsewhere, promiscuous gene expression and
dominant tolerance are closely linked both experimentally
and conceptually (4, 49, 50). Dominant tolerance, as op-
posed to recessive tolerance, offers a mechanism to com-
pensate for incomplete representation of self in the thymus.
Thus, in case of   cells of the pancreas, T regulator cells
specific for GAD67 could also contain the autosensitization
of naive T effector cells specific for GAD65, when both
antigens are copresented by the same DC, a mechanism
termed bystander or linked suppression (51). Since thymic
expression levels of self-antigens do, however, correlate
with susceptibility to autoimmunity, the protection af-
forded by bystander suppression may be more easily
breached than cognate suppression.
The structural and functional diversity of promiscuously
expressed genes and their expression uncoupled from cell
lineage specificity and temporal regulation poses a puzzle as
to their molecular regulation. In this respect, the finding
that the transcription (co) factor Aire regulates a host of
promiscuously expressed genes provided an important step
toward the molecular definition of this phenomenon (8).
Moreover, the fact that Aire also regulates a truncated pro-
motor (the rat insulin promotor) in a transgenic context
across species barriers implies sequence-specific genetic
control, at least as far as the Aire-dependent pool is con-
cerned (52). DNA-encoded sequences, however, are only
one aspect of gene regulation; genetic regulation itself is
controlled by epigenetic mechanisms targeting genes,
which share common chromosomal location. The highly
significant clustering of overexpressed genes supports a role
for epigenetic regulation in this case. Clustering was signif-
icant for triplets and quadruplets by statistical analysis.
These findings are reminiscent of recent reports showing
clustering of nonhomologous genes coexpressed in a par-
ticular tissue in C. elegans and D. melanogaster (21, 30). This
clustering has been interpreted as the result of juxtaposition
during evolution of genes involved in formation of a par-
ticular tissue, thus facilitating their coregulation. In con-
trast, promiscuously expressed genes obviously do not share
such a function; hence, we interpret the clustering as the
result of colocalization in chromatin domains which be-
come accessible in mTECs irrespective of tissue-specific
differentiation patterns akin to recently described “gene ex-
pression neighborhoods” (53). For this reason, we did not
exclude homologous genes like those of the keratin type-I
and -II group in our analysis, since individual members of
these genes are expressed differentially in a tissue-specific
manner and their coexpression in purified mTECs violates
this regulation. However, clustering is not confined to ho-
mologous genes (Fig. 4 d). It will be important to define
the actual size of such expression domains and their bound-
aries and to determine whether expression is contiguous
within such domains as suggested by preliminary data
(Derbinski, J., personal communication). We emphasizeGotter et al. 165
that expression of nonhomologous genes of different ontol-
ogy in such domains points to epigenetic regulation but
does not prove it.
The species conservation of promiscuous gene expression
between mouse and man as documented in this study
strengthens the validity of analogies drawn between human
autoimmune diseases and corresponding experimental ani-
mal models. The extent of promiscuous gene expression by
human mTECs and the composition of this gene pool po-
tentially extends the scope of central tolerance to most pe-
ripheral tissues including self-constituents, which are only
encountered during adulthood, e.g., in the lactating mam-
mary gland or placenta. Promiscuous gene expression is not
only sufficient for self-tolerance but likely has been essential
for survival of the species (54), given the high prevalence of
infertility associated with gonad-specific autoimmunity in
APS-1 patients (44) and in AIRE /  mice (7, 8). The iden-
tification of mTECs as the responsible cell type and its puri-
fication will permit expression studies to be conducted in a
standardized fashion, which has not been possible to date.
This will be a prerequisite to establish a database on promis-
cuous gene expression in humans, thereby documenting in-
terindividual differences (11, 14), allelic polymorphisms (40,
41), and splice variants (55). The identification of the mo-
lecular mechanisms and genes responsible for the regulation
of promiscuous gene expression and its deviations will
hopefully aid our understanding of the complex genetic
control of human autoimmune disease.
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